AKT1 and neoplasm: Another study based on BCa cells indicated that inhibition of GP130 could enhance the sensitivity to GEM and reduce viability and migration of tumor cells through regulating the PI3K/AKT/mTOR signaling pathways (Li X. et al., 2019).